WWP1 specifically targets HER4 JM-a/CYT1 isoforms for ubiquitination and degradation, thereby modulating HER4 bioactivity in BC cells (Li et al., 2009; Feng et al., 2009). This evidence concerns the gene ERBB4 and breast cancer.